Sequential topoisomerase I (topo I) and topoisomerase II (topo II) inhibitors in relapsed/refractory aggressive NHL: Results of CALGB 59906, a phase II study of doxorubicin and topotecan.
Smith, SM; Johnson, JL; Niedzwiecki, D; Eder, JP; Canellos, GP; Cheson, BD; Bartlett, NL
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
46th Annual Meeting of the American-Society-of-Hematology
Conference Start Date
Conference End Date